Glaxo stumbles in race for new kind of AIDS drug (Reuters)
Reuters - GlaxoSmithKline Plc has suffered a
setback in the race to develop a new kind of AIDS pill,
following two cases of serious liver problems in patients
taking its experimental drug aplaviroc.